Symptom-triggered therapy for alcohol withdrawal syndrome in medical inpatients

Mayo Clinic Proceedings

Volumn 76, Issue 7, 2001, Pages 695-701

  Jaeger, Thomas M ^a   Lohr, Robert H ^a   Shane Pankratz, V ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; BENZODIAZEPINE; CHLORDIAZEPOXIDE; CLONAZEPAM; CLORAZEPATE; CLORAZEPATE DIPOTASSIUM; DIAZEPAM; FLURAZEPAM; HALAZEPAM; LORAZEPAM; OXAZEPAM; PRAZEPAM; TEMAZEPAM; TRIAZOLAM;

ADULT; AGED; ALCOHOL WITHDRAWAL; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DELIRIUM TREMENS; DRUG UTILIZATION; FEMALE; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; OUTCOMES RESEARCH; SEIZURE; STATISTICAL ANALYSIS; SYMPTOM; UNITED STATES;

EID: 0034960818     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/76.7.695     Document Type: Article

References (13)

1. Mayo-Smith MF, American Society of Addiction Medicine Working Group on Pharmacological Management of Alcohol Withdrawal. Pharmacological management of alcohol withdrawal: a meta-analysis and evidence-based practice guideline. JAMA. 1997;278:144-151.
2. Saitz R, Friedman LS, Mayo-Smith MF. Alcohol withdrawal: a nationwide survey of inpatient treatment practices. J Gen Intern Med. 1995;10:479-487.
3. Sereny G, Kalant H. Comparative clinical evaluation of chlordiazepoxide and promazine in treatment of alcohol-withdrawal syndrome. BMJ. 1965; 1:92-97.
4. Sellers EM, Naranjo CA, Harrison M, Devenyi P, Roach C, Sykora K. Diazepam loading: simplified treatment of alcohol withdrawal. Clin Pharmacol Ther. 1983;34:822-826.
5. Kaim SC, Klett CJ, Rothfeld B. Treatment of the acute alcohol withdrawal state: a comparison of four drugs. Am J Psychiatry. 1969; 125:1640-1646.
6. Saitz R, Mayo-Smith MF, Roberts MS, Redmond HA, Bernard DR, Calkins DR. Individualized treatment for alcohol withdrawal: a randomized double blind controlled trial. JAMA. 1994;272:519523.
7. Sullivan JT, Sykora K, Schneiderman J, Naranjo CA, Sellers EM. Assessment of alcohol withdrawal: the revised Clinical Institute Withdrawal Assessment for Alcohol scale (CIWA-Ar). Br J Addict. 1989;84:1353-1357.
8. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. / Chronic Dis. 1987;40:373-383.
9. Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika. 1986;73:13-22.
10. Sullivan JT, Swift RM, Lewis DC. Benzodiazepine requirements during alcohol withdrawal syndrome: clinical implications of using a standardized withdrawal scale. J Clin Psychopharmacol. 1991 ; 11:291-295.
11. Gerke P, Hapke U, Rumpf HJ, John U. Alcohol-related diseases in general hospital patients. Alcohol Alcohol. 1997;32:179-184.
12. Ferguson JA, Suelzer CJ, Eckert GJ, Zhou XH, Dittus RS. Risk factors for delirium tremens development. J Gen Intern Med. 1996; 11:410-414.
13. Schuckit MA, Tipp JE, Reich T, Hesselbrock VM, Bucholz KK. The histories of withdrawal convulsions and delirium tremens in 1648 alcohol dependent subjects. Addiction. 1995;90:13351347.